Neumora director granted options on 80,000 shares
Neumora Therapeutics, Inc. director Alaa Halawa received a grant of stock options covering 80,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Neumora Therapeutics, Inc. director Alaa Halawa received a grant of stock options covering 80,000 shares of common stock. The options carry an exercise price of $1.86 per share and expire on May 26, 2036. All 80,000 option shares vest on the earlier of the one-year anniversary of May 27, 2026 or immediately before the next annual meeting following that date.
Insider Trade Summary
Grant/Award: 80,000 shares
Grant/Award
1 txn
Insider
Halawa Alaa
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 80,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 80,000 contracts (Direct)
Footnotes (1)
- F1. 100% of the shares subject to the option vest on the earlier of (i) the one year anniversary of May 27, 2026 or (ii) immediately prior to the next Annual Meeting following May 27, 2026.
Key Figures
Option shares granted: 80,000 shares
Exercise price: $1.86 per share
Total options after grant: 80,000 options
+3 more
6 metrics
Option shares granted
80,000 shares
Stock Option (Right to Buy) grant to director
Exercise price
$1.86 per share
Conversion or exercise price of the option
Total options after grant
80,000 options
Total derivative securities following transaction
Expiration date
May 26, 2036
Option expiration
Underlying common stock
80,000 shares
Underlying security for the option
Vesting trigger date reference
May 27, 2026
Used to define one-year anniversary vesting condition
Key Terms
Stock Option (Right to Buy), Grant, award, or other acquisition, exercise price, Annual Meeting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
exercise price financial
"conversion_or_exercise_price: "1.8600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Annual Meeting regulatory
"immediately prior to the next Annual Meeting following May 27, 2026."
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
derivative securities financial
"derivativeTransactionCount for derivative-type records"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Neumora Therapeutics (NMRA) report for Alaa Halawa?
Neumora Therapeutics reported that director Alaa Halawa received a grant of stock options for 80,000 shares of common stock. This is a compensation-related award, not an open-market purchase or sale, and reflects equity-based pay for board service.
What is the exercise price of Alaa Halawa’s new options at Neumora Therapeutics (NMRA)?
The granted stock options to director Alaa Halawa have an exercise price of $1.86 per share. This means Halawa can purchase Neumora common stock at $1.86 per share once the options vest and are exercised, subject to the option terms.
When do Alaa Halawa’s Neumora Therapeutics (NMRA) options vest?
All 80,000 option shares vest 100% on the earlier of the one-year anniversary of May 27, 2026 or immediately before the next annual meeting following that date. This single-vesting schedule ties the award to continued board service through that milestone.
When do Alaa Halawa’s Neumora Therapeutics (NMRA) options expire?
The stock options granted to director Alaa Halawa expire on May 26, 2036. After that expiration date, any unexercised options become worthless, so potential value must be realized by exercising before expiration, subject to vesting and other conditions.
Is Alaa Halawa’s Form 4 transaction in Neumora Therapeutics (NMRA) a buy or a grant?
The Form 4 reports a grant/award acquisition of stock options, not an open-market buy. Transaction code “A” indicates a compensation-related award, with 80,000 option shares acquired at a stated exercise price, rather than shares purchased on the market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates